Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00914511 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects
A Phase 1 study of Avanfil ADME and Semen Exposure, sponsored by VIVUS.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT00914511: Completed Phase 1 study of Avanfil ADME and Semen Exposure, sponsored by VIVUS.
NCT00914511 is a Phase 1 study of Avanfil ADME and Semen Exposure that has completed, run by VIVUS. The registered enrollment target is 32 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00914511, a Phase 1 study of Avanfil ADME and Semen Exposure, has completed, sponsored by VIVUS.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purposes of this study are to: * Determine the effect of the study drug on sperm and semen of healthy young male subjects. * Determine the effect of age on the amount of study drug in the blood of healthy subjects * Learn about the safety of the study drug. * Learn how subjects tolerate the study drug.
Conditions Studied
Interventions
- DRUG avanafil 200mg
Study Locations (1)
Arizona
- MDS Pharma Services - Tempe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-06 |
| Phase | Phase 1 |
What the finished NCT00914511 record still lists
NCT00914511 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower).
The record links to 3 conditions, with Avanfil ADME appearing as the primary indexed condition, and to 1 intervention - of which avanafil 200mg is the first listed.
NCT00914511 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT00914511 about?
NCT00914511 is a clinical study titled "A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects". The purposes of this study are to: * Determine the effect of the study drug on sperm and semen of healthy young male subjects. * Determine the effect of age on the amount of study drug in the blood of healthy subjects * Learn about the safety of the study drug. * Learn how subjects tolerate the stu...
What is the current status of trial NCT00914511?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2009-05. Estimated completion is 2009-06.
What conditions does trial NCT00914511 study?
This clinical trial studies the following conditions: Avanfil ADME, Semen Exposure, Sperm Function.
What interventions are being tested in trial NCT00914511?
The interventions under investigation include: avanafil 200mg (DRUG).
Who is sponsoring clinical trial NCT00914511?
This trial is sponsored by VIVUS, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00914511 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00914511's enrollment target sits among peer trials
32 1296th of 2000 higher than 679 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia